Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Basilea names new commercial head

This article was originally published in Scrip

Executive Summary

Basilea Pharmaceutica, which develops products in the therapeutic areas of bacterial infections, fungal infections and oncology, has named David Veitch chief commercial officer – effective 1 September 2014. Mr Veitch will be responsible for leading Basilea's commercial operations, including sales, marketing, pricing and market access, and will report to chief executive officer Ronald Scott. Prior to joining the Basel, Switzerland-based firm, Mr Veitch was president of European operations at Savient Pharmaceuticals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC026091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel